Researchers at Mount Sinai have developed a groundbreaking artificial intelligence tool called V2P (Variant to Phenotype) that goes beyond simply spotting disease-causing genetic mutations. V2P is designed to predict the type of disease those mutations are likely to trigger, offering clinicians and scientists a powerful new diagnostic aid. By linking genetic variants directly to their predicted disease effects, V2P significantly accelerates diagnostics and aids in the discovery of new therapeutic targets for complex and rare diseases.
Source: Icahn School of Medicine at Mount Sinai
Leave a Reply